139 related articles for article (PubMed ID: 18470703)
1. Body distribution of poly(D,L-lactide-co-glycolide) copolymer degradation products in rats.
Hua N; Sun J
J Mater Sci Mater Med; 2008 Oct; 19(10):3243-8. PubMed ID: 18470703
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents.
Ma X; Oyamada S; Wu T; Robich MP; Wu H; Wang X; Buchholz B; McCarthy S; Bianchi CF; Sellke FW; Laham R
J Biomed Mater Res A; 2011 Mar; 96(4):632-8. PubMed ID: 21268237
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain.
Emerich DF; Tracy MA; Ward KL; Figueiredo M; Qian R; Henschel C; Bartus RT
Cell Transplant; 1999; 8(1):47-58. PubMed ID: 10338275
[TBL] [Abstract][Full Text] [Related]
5. In-patient versus in vitro degradation of P(L/DL)LA and PLGA.
Landes CA; Ballon A; Roth C
J Biomed Mater Res B Appl Biomater; 2006 Feb; 76(2):403-11. PubMed ID: 16184534
[TBL] [Abstract][Full Text] [Related]
6. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Vandorpe J; Schacht E; Dunn S; Hawley A; Stolnik S; Davis SS; Garnett MC; Davies MC; Illum L
Biomaterials; 1997 Sep; 18(17):1147-52. PubMed ID: 9259511
[TBL] [Abstract][Full Text] [Related]
7. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.
Ozalp Y; Ozdemir N; Hasirci V
J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762
[TBL] [Abstract][Full Text] [Related]
9. Development of a sustained-release system for perivascular delivery of dipyridamole.
Zhu W; Masaki T; Bae YH; Rathi R; Cheung AK; Kern SE
J Biomed Mater Res B Appl Biomater; 2006 Apr; 77(1):135-43. PubMed ID: 16206204
[TBL] [Abstract][Full Text] [Related]
10. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
Sankar R; Ravikumar V
Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation.
Ji W; Yang F; Seyednejad H; Chen Z; Hennink WE; Anderson JM; van den Beucken JJ; Jansen JA
Biomaterials; 2012 Oct; 33(28):6604-14. PubMed ID: 22770568
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.
Lam XM; Duenas ET; Cleland JL
J Pharm Sci; 2001 Sep; 90(9):1356-65. PubMed ID: 11745788
[TBL] [Abstract][Full Text] [Related]
14. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres.
Stevanović M; Maksin T; Petković J; Filipic M; Uskoković D
Nanotechnology; 2009 Aug; 20(33):335102. PubMed ID: 19636100
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
Kohane DS; Lipp M; Kinney RC; Anthony DC; Louis DN; Lotan N; Langer R
J Biomed Mater Res; 2002 Mar; 59(3):450-9. PubMed ID: 11774302
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro cytotoxicity and modulation of the inflammatory response by the bioresorbable polymers poly(D,L-lactide-co-glycolide) and poly(L-lactide-co-glycolide).
Geddes L; Themistou E; Burrows JF; Buchanan FJ; Carson L
Acta Biomater; 2021 Oct; 134():261-275. PubMed ID: 34329786
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of elastic PLGA/PCL/PLGA tri-block copolymers.
Choi SH; Park TG
J Biomater Sci Polym Ed; 2002; 13(10):1163-73. PubMed ID: 12484491
[TBL] [Abstract][Full Text] [Related]
18. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
Khan A; Benboubetra M; Sayyed PZ; Ng KW; Fox S; Beck G; Benter IF; Akhtar S
J Drug Target; 2004 Jul; 12(6):393-404. PubMed ID: 15545089
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres.
Roullin VG; Deverre JR; Lemaire L; Hindré F; Venier-Julienne MC; Vienet R; Benoit JP
Eur J Pharm Biopharm; 2002 May; 53(3):293-9. PubMed ID: 11976017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
